An automated database case definition for serious bleeding related to oral anticoagulant use

Andrew Cunningham1, C Michael Stein, Cecilia P Chung

  • 1Division of Clinical Pharmacology, Department of Medicine, Nashville, TN, USA.

Insights

An automated database case definition accurately identified bleeding-related hospitalizations. This tool achieved high positive predictive value (89-99%) and could specify bleeding anatomical sites for epidemiologic studies.

Area of Science:

  • Pharmacovigilance
  • Health Informatics
  • Epidemiology

Background:

  • Bleeding complications are a significant risk associated with anticoagulant medications.
  • Accurate identification of bleeding events is crucial for epidemiological research.

Purpose of the Study:

  • To develop and validate an automated database case definition for bleeding-related hospitalizations.
  • To facilitate large-scale epidemiologic investigations of adverse bleeding events.

Main Methods:

  • A retrospective cohort study of warfarin-related bleeding in Tennessee Medicaid enrollees (1990-2005).
  • Developed an automated definition using inpatient diagnoses and procedures indicative of bleeding.
  • Validated the definition through medical record review of 236 hospitalizations.

Main Results:

  • The automated definition demonstrated a high positive predictive value (PPV) of 89% for bleeding-related hospitalizations.
  • Clinical confirmation of bleeding was achieved in 89% of cases.
  • The definition accurately identified specific anatomical sites of bleeding with 99% concordance (e.g., gastrointestinal, cerebral, genitourinary).

Conclusions:

  • An automated database case definition for bleeding-related hospitalizations is effective and reliable.
  • The developed definition has a high PPV (89-99%) and can accurately distinguish bleeding sites.
  • This tool supports efficient and accurate epidemiologic research on bleeding complications.
Abstract

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
Hemorrhagic Stroke l: Introduction01:17

Hemorrhagic Stroke l: Introduction

A hemorrhagic stroke is an acute neurological event that occurs when a weakened cerebral blood vessel ruptures, allowing blood to accumulate within or around the brain. The sudden release of blood forms a focal hematoma that increases intracranial pressure, displaces neural tissue, and can obstruct cerebrospinal fluid pathways. These effects may be compounded by intraventricular extension of the hemorrhage, cerebral edema, or compression of adjacent structures, all of which contribute to...